6.65
0.00%
0.00
After Hours:
6.62
-0.03
-0.45%
Voyager Therapeutics Inc stock is traded at $6.65, with a volume of 478.05K.
It is up +0.00% in the last 24 hours and down -5.54% over the past month.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
See More
Previous Close:
$6.65
Open:
$6.54
24h Volume:
478.05K
Relative Volume:
0.90
Market Cap:
$361.83M
Revenue:
$250.01M
Net Income/Loss:
$132.33M
P/E Ratio:
2.9295
EPS:
2.27
Net Cash Flow:
$74.66M
1W Performance:
-5.94%
1M Performance:
-5.54%
6M Performance:
-24.52%
1Y Performance:
-0.89%
Voyager Therapeutics Inc Stock (VYGR) Company Profile
Name
Voyager Therapeutics Inc
Sector
Industry
Phone
857-259-5340
Address
75 HAYDEN AVENUE, LEXINGTON, MA
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-10-23 | Initiated | Truist | Buy |
Mar-10-23 | Initiated | Oppenheimer | Outperform |
Oct-07-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
Feb-26-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
Feb-03-21 | Downgrade | BTIG Research | Buy → Neutral |
Feb-03-21 | Downgrade | Wedbush | Outperform → Neutral |
Dec-24-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
Dec-23-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
Nov-11-20 | Downgrade | Oppenheimer | Outperform → Perform |
Nov-10-20 | Downgrade | Raymond James | Strong Buy → Outperform |
Nov-10-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Mar-19-20 | Initiated | The Benchmark Company | Buy |
Feb-06-20 | Initiated | Oppenheimer | Outperform |
Nov-15-18 | Upgrade | Raymond James | Outperform → Strong Buy |
Sep-10-18 | Resumed | BTIG Research | Buy |
Sep-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jun-04-18 | Initiated | H.C. Wainwright | Buy |
Mar-12-18 | Downgrade | Evercore ISI | Outperform → In-line |
Mar-12-18 | Downgrade | Wedbush | Outperform → Neutral |
Feb-02-18 | Initiated | Morgan Stanley | Overweight |
Nov-28-17 | Resumed | Piper Jaffray | Overweight |
Oct-31-17 | Initiated | Robert W. Baird | Outperform |
Oct-27-17 | Initiated | Canaccord Genuity | Buy |
Oct-23-17 | Reiterated | Stifel | Buy |
Oct-12-17 | Initiated | Raymond James | Outperform |
Aug-17-17 | Initiated | Evercore ISI | Outperform |
Jul-28-17 | Resumed | Stifel | Buy |
View All
Voyager Therapeutics Inc Stock (VYGR) Latest News
VYGRVoyager Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast - StockTitan
Learn to Evaluate (VYGR) using the Charts - Stock Traders Daily
Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Buy at StockNews.com - MarketBeat
Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Canada Finance
Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $17.43 - MarketBeat
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Analysts - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Earns Buy Rating from HC Wainwright - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Stock Rating Lowered by StockNews.com - Defense World
StockNews.com Lowers Voyager Therapeutics (NASDAQ:VYGR) to Hold - MarketBeat
How to Take Advantage of moves in (VYGR) - Stock Traders Daily
HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat
Equities Analysts Offer Predictions for VYGR Q3 Earnings - MarketBeat
Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Strong-Buy at Leerink Partnrs - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Upgraded at Leerink Partnrs - MarketBeat
Improved Revenues Required Before Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock's 27% Jump Looks Justified - Simply Wall St
Leerink Partners Begins Coverage on Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics - Benzinga
The Manufacturers Life Insurance Company Increases Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Gene Therapy in CNS Disorder Market Rapid Growth at Deep Value Price :Voyager Therapeutics, Spark Therapeutics, Novartis – IndiaPolitics.com - IndiaPolitics.com
(VYGR) Technical Pivots with Risk Controls - Stock Traders Daily
Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.
Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain - Yahoo Finance
Intracranial Therapeutic Market Rewriting its Growth Cycle |Novartis AG, BioMarin, CORESTEM Inc., Alaunos Therapeutics, – IndiaPolitics.com - IndiaPolitics.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Short Interest Update - MarketBeat
Voyager Therapeutics Inc (VYGR)’s Market Momentum: Closing Strong at 6.76, Down -4.52 - The Dwinnex
Monitoring Voyager Therapeutics Inc (VYGR) after recent insider movements - Knox Daily
Analyzing the Impact of Earnings Reports on Voyager Therapeutics Inc Inc. (VYGR) Price Performance - The InvestChronicle
Nothing is Better Than Voyager Therapeutics Inc (VYGR) stock at the moment - SETE News
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock Holdings Lessened by Dimensional Fund Advisors LP - MarketBeat
Are Voyager Therapeutics Inc (VYGR) shares a good deal now? - US Post News
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength? - Yahoo Finance
Strong week for Voyager Therapeutics (NASDAQ:VYGR) shareholders doesn't alleviate pain of five-year loss - Simply Wall St
AQR Capital Management LLC Sells 291,259 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Voyager Therapeutics executive sells shares worth over $34k By Investing.com - Investing.com Australia
Voyager Therapeutics Inc [VYGR] stock for 34,914 USD was sold by Fahey Sandell Jacquelyn - Knox Daily
Voyager Therapeutics Inc (VYGR) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
What is the investor’s view on Voyager Therapeutics Inc (VYGR)? - US Post News
(VYGR) Technical Data - Stock Traders Daily
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Insider Sells $34,914.18 in Stock - MarketBeat
Voyager Therapeutics executive sells shares worth over $34k - Investing.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Voyager Therapeutics GAAP EPS of -$0.20 beats by $0.24, revenue of $19.5M beats by $10.02M - MSN
Armistice Capital LLC Raises Stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Voyager Therapeutics stock hits 52-week low at $5.95 By Investing.com - Investing.com Australia
Baird maintains Outperform rating on Voyager Therapeutics stock By Investing.com - Investing.com Canada
Closing Figures: Voyager Therapeutics Inc (VYGR)’s Negative Finish at 6.04, Down -0.98 - The Dwinnex
Voyager Therapeutics stock hits 52-week low at $5.95 - Investing.com
Great Point Partners LLC Invests $12.67 Million in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
What is Voyager Therapeutics Inc (VYGR) Stock Return on Shareholders’ Capital? - SETE News
(VYGR) Trading Report - Stock Traders Daily
Voyager Therapeutics Inc Stock (VYGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):